🔗 Share this article

The prestigious award in Physiology or Medicine has been awarded for transformative findings that clarify how the body's defense network targets harmful infections while protecting the body's own cells.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and US scientists Mary Brunkow and Fred Ramsdell—share this accolade.

The research identified unique "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the body.

These findings are now paving the way for innovative therapies for immune disorders and malignancies.

These laureates will divide a prize fund worth 11 million Swedish kronor.

Crucial Findings

"Their work has been essential for comprehending how the body's defenses operates and the reason we do not all suffer from serious self-attack conditions," commented the chair of the award panel.

This team's research address a core question: How does the immune system protect us from numerous infections while leaving our own tissues unharmed?

The body's protection system employs immune cells that scan for signs of infection, even pathogens and bacteria it has never encountered.

These cells utilize detectors—called receptors—that are produced by chance in a vast number of variations.

This provides the defense network the capacity to combat a broad range of invaders, but the randomness of the mechanism inevitably creates white blood cells that may attack the body.

Security Guards of the Immune System

Researchers previously understood that some of these harmful defense cells were destroyed in the thymus—the site where immune cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the immune system's "security guards"—which patrol the body to neutralize other defenders that attack the healthy cells.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

The prize committee added, "The discoveries have established a new field of research and accelerated the creation of new therapies, for instance for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells block the body from attacking the tumor, so studies are focused on reducing their numbers.

In self-attack disorders, experiments are exploring increasing regulatory T-cells so the organism is no longer being harmed. A comparable method could also be effective in minimizing the risks of organ transplant rejection.

Innovative Experiments

Prof Sakaguchi, of Osaka University, performed experiments on rodents that had their immune gland removed, causing self-attack conditions.

The researcher demonstrated that injecting immune cells from other mice could stop the disease—implying there was a mechanism for blocking immune cells from harming the host.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at a biotech firm in San Francisco, were studying an genetic immune disorder in rodents and humans that resulted in the discovery of a genetic factor vital for the way T-regs operate.

"Their pioneering work has uncovered how the immune system is kept in check by regulatory T cells, stopping it from accidentally targeting the healthy cells," said a prominent physiology expert.

"The research is a striking illustration of how fundamental biological research can have broad implications for human health."